• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

daiichi sankyo


<



















Pay doesn't justify everything. Stabbing, kicking and cutting each other throats is just wrong, no matter the pay. Violation of compliance and risking patient health can even less be bought off.
 








Similar threads

Replies
18
Views
2K
Replies
7
Views
1K